| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +12.5K | 100% | $4.43 | +$55.4K |
| Sells | 0 | ||||
| Net | +1 | +12.5K | 100% | +$55.4K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Sotirios Stergiopoulos | Director | $16.6M | Sep 17, 2021 | ||
| Bihua Chen | Director, 10%+ Owner | $15.8M | Jun 12, 2024 | ||
| A2A Pharmaceuticals, Inc. | 10%+ Owner | $13.2M | May 31, 2023 | ||
| Rainer M. Erdtmann | President and COO, Director | $3.73M | Jan 17, 2024 | ||
| Franco Valle | Chief Financial Officer | $188K | +$55.4K | +41.7% | Jun 11, 2024 |
| Juan Pablo Frias | Chief Medical Officer | $3.12K | May 31, 2024 | ||
| Sumita Ray | Director | Jun 12, 2024 | |||
| Thomas Andrew Butler | Chief Executive Officer, Director, 10%+ Owner | Jan 17, 2024 | |||
| Biomea Health, LLC | 10%+ Owner | Jun 1, 2022 | |||
| Michael J.M. Hitchcock | Director | Jun 12, 2024 | |||
| Elizabeth Faust | Director | Jun 12, 2024 | |||
| Eric Aguiar | Director | Jun 12, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|